Strategic Partnerships Hubly is actively expanding its market through new client Vizient, Inc. contract awards, signaling growth opportunities with large healthcare networks and group purchasing organizations that can drive adoption of the Hubly Auto-Stop Drill and Cranial Access Kit.

Clinical Validation Recent recognition including the Human Health Prize and FDA 510(k) clearance milestones bolster credibility with hospitals and clinics, easing outreach to decision makers who prioritize validated safety and regulatory compliance in bedside intracranial access solutions.

Bedside Adoption The single-use cordless design and one-handed operation position Hubly as a practical choice for reducing OR dependence, opening conversations with hospital administrators on cost containment, operating room efficiency, and bedside access programs.

Market Readiness With a revenue range of one to ten million and an entrepreneurial growth profile, Hubly can target mid-to-large healthcare systems as a scalable, incremental upgrade to existing neurosurgical workflows and post-market data initiatives.

Targeted Outreach Key stakeholders to engage include supply chain and procurement leaders through Vizient discussions, neuroscience department heads, and OR managers who oversee intracranial procedures and would benefit from safer, faster bedside drilling capabilities.